a
a
Home2023January (Page 38)

S&P Futures 4,036.75 +4.75(+0.12%)   Dow Futures 33,829.00 +6.00(+0.02%)   Nasdaq Futures 11,916.75 +43.50(+0.37%)   Russell 2000 Futures 1,900.80 +1.30(+0.07%)   Crude Oil 80.28 +0.13(+0.16%)   Gold 1,947.00 +4.40(+0.23%)   Silver 23.99 +0.04(+0.18%)   EUR/USD 1.0916 -0.0004(-0.03%)   10-Yr Bond 3.4620 -0.0070(-0.20%)   Vix 19.08 -0.12(-0.63%)   GBP/USD 1.2396 -0.0006(-0.05%)   USD/JPY 129.2760 -0.2330(-0.18%)   BTC-USD 23,189.43 +542.91(+2.40%)   CMC Crypto 200 527.10 +15.78(+3.09%)   FTSE 100 7,744.87 -12.49(-0.16%)   Nikkei 225 27,318.31 -76.70(-0.28%)   Investors did not like the latest update from Alzheimer's drug maker Cassava Sciences (NASDAQ:SAVA). After showing excellent results from the first 50 patients treated with simufilam, the company's prospective Alzheimer’s drug in an open-label